EXEMESTANE, ANASTROZOLE, LETROZOLE
UC-BCG-2103
Phase 2 small_molecule active
Quick answer
EXEMESTANE, ANASTROZOLE, LETROZOLE for Post-menopausal women with localized luminal A breast cancer and considered at low risk of metastatic relapse is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Post-menopausal women with localized luminal A breast cancer and considered at low risk of metastatic relapse
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active